0.1100
+0.0050
+(4.76%)
At close: 4:10:57 PM GMT+10
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
Cash Flows from Used in Operating Activities Direct
-2,292.8480
-2,292.8480
-1,470.8760
-1,859.1620
Investing Cash Flow
506.5720
506.5720
-557.3880
-115.8940
Financing Cash Flow
818.7050
818.7050
1,997.5580
1,515.5660
End Cash Position
711.9090
711.9090
1,679.4800
1,710.1860
Capital Expenditure
-4.9800
-4.9800
-45.8360
-115.8940
Issuance of Capital Stock
--
--
2,205
1,628.8010
Issuance of Debt
905
905
--
--
Repurchase of Capital Stock
--
--
-137.8500
-103.4620
Free Cash Flow
-2,297.8280
-2,297.8280
-1,516.7120
-1,975.0560
6/30/2022 - 11/25/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IXC.AX Invex Therapeutics Ltd
0.0700
0.00%
NSB.AX NeuroScientific Biopharmaceuticals Limited
0.0350
0.00%
BTC.AX BTC Health Limited
0.0460
-8.00%
VBS.AX Vectus Biosystems Limited
0.0800
0.00%
TRP.AX Tissue Repair Ltd
0.2400
0.00%
ANR.AX Anatara Lifesciences Ltd
0.0060
0.00%
1AI.AX Algorae Pharmaceuticals Limited
0.0060
+20.00%
BGT.AX Bio-Gene Technology Limited
0.0310
0.00%
ATX.AX Amplia Therapeutics Limited
0.0520
-1.89%
CMB.AX Cambium Bio Limited
0.3000
+7.14%